63.66 -0.05 (-0.08%)
Pre-market: 5:30AM EST
|Bid||62.51 x 1200|
|Ask||63.67 x 1800|
|Day's range||62.81 - 64.23|
|52-week range||56.56 - 85.97|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||650.10|
|Forward dividend & yield||2.84 (4.46%)|
|Ex-dividend date||12 Mar 2021|
|1y target est||N/A|
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...
Gilead (GILD) and partner Galapagos announce their decision to discontinue development of ziritaxestat in patients with idiopathic pulmonary fibrosis.